SenzaGen AB (SENZA)

Currency in SEK
6.18
-0.12(-1.90%)
Closed·
SENZA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SENZA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.106.36
52 wk Range
3.868.20
Key Statistics
Prev. Close
6.3
Open
6.36
Day's Range
6.1-6.36
52 wk Range
3.86-8.2
Volume
3.03K
Average Volume (3m)
24.08K
1-Year Change
-16.56%
Book Value / Share
2.59
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SENZA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

SenzaGen AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

SenzaGen AB Company Profile

SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also provides biological evaluation, in vitro biocompatibility testing, cytotoxicity, irritation, and skin sensitization medical device services; advisory services for medical devices; and substance based medical devices. In addition, the company offers regulatory toxicity testing services, including skin corrosion, skin irritation, skin sensitization, and skin absorption; and eye irritation, phototoxicity, and genotoxicity testing services. Further, it provides advisory services, such as pharma, medical devices, cosmetics, and chemical. The company offers services through license partners and distributors. It has a collaboration agreement with the Research Institute for Fragrance Materials to develop tests for photosensitization. SenzaGen AB was incorporated in 2010 and is headquartered in Lund, Sweden.

SenzaGen AB Earnings Call Summary for Q2/2025

  • SenzaGen's Q2 2025 earnings show 63% order intake target achieved, 43% direct selling, with stock rising 5.2% post-announcement
  • Revenue grew 9.82% YoY with 67.01% gross profit margin; company expanding into medical device testing and new industry sectors
  • Strong financial health with more cash than debt; market cap at $17.37M and current ratio of 2.97, suggesting undervaluation
  • Positive regulatory signals support growth initiatives; company plans to expand vitro screens platform despite projected unprofitability
  • Risks include regulatory hurdles in new markets, intense competition, and economic uncertainties affecting customer spending
Last Updated: 20/08/2025, 10:02
Read Full Transcript

Compare SENZA to Peers and Sector

Metrics to compare
SENZA
Peers
Sector
Relationship
P/E Ratio
−11.3x−9.9x−0.6x
PEG Ratio
−0.40−0.210.00
Price/Book
2.4x7.2x2.6x
Price / LTM Sales
3.3x43.9x3.3x
Upside (Analyst Target)
110.4%16.7%38.7%
Fair Value Upside
Unlock9.8%5.1%Unlock

Earnings

Latest Release
Aug 20, 2025
EPS / Forecast
-0.18 / --
Revenue / Forecast
15.90M / 19.00M
EPS Revisions
Last 90 days

SENZA Income Statement

FAQ

What Stock Exchange Does SenzaGen Trade On?

SenzaGen is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for SenzaGen?

The stock symbol for SenzaGen is "SENZA."

What Is the SenzaGen Market Cap?

As of today, SenzaGen market cap is 182.33M.

What Is SenzaGen's Earnings Per Share (TTM)?

The SenzaGen EPS (TTM) is -0.60.

When Is the Next SenzaGen Earnings Date?

SenzaGen will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is SENZA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has SenzaGen Stock Split?

SenzaGen has split 1 times.

How Many Employees Does SenzaGen Have?

SenzaGen has 37 employees.

What is the current trading status of SenzaGen (SENZA)?

As of 28 Aug 2025, SenzaGen (SENZA) is trading at a price of 6.18, with a previous close of 6.30. The stock has fluctuated within a day range of 6.10 to 6.36, while its 52-week range spans from 3.86 to 8.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.